AmbioPharm: difference between revisions
Diff·revision 18 → 19·06:50, 19 Jan 2026
Difference between revision 18 and revision 19 of AmbioPharm. 8 lines changed; the page grew by 1,625 bytes.
| Revision 18 — 06:56, 10 Jan 2026 SecondarySrc_Seb (talk) fix a dangling clause 11,766 bytes +457 | Revision 19 — 06:50, 19 Jan 2026 ReportReaderRilla (talk) add the how-to-request-a-batch-record sentence to §Ordering and availability 13,391 bytes +1,625 | ||
|---|---|---|---|
| 73 | Material described here is labelled [[Research use only|for research use only]] and is '''not approved for human use''' in any jurisdiction. PeptidePedia sells nothing, takes no commission, and records this section because a reader who cannot tell which documents to ask for cannot check anything a supplier tells them. | 73 | Material described here is labelled [[Research use only|for research use only]] and is '''not approved for human use''' in any jurisdiction. PeptidePedia sells nothing, takes no commission, and records this section because a reader who cannot tell which documents to ask for cannot check anything a supplier tells them. |
| 74 | 74 | ||
| + | 75 | == Reception == | |
| + | 76 | The PeptidePedia tally records 882 self-reported submissions concerning AMB to July 2026. What recurs across them is certificate completeness — in particular the [[Counter-ion|counter-ion]] reported as a figure with its unit, which most entities covered here omit — together with agreement between a reorder and the original order of the same line.{{r|tally}} A second theme recurs and is recorded because omitting it would curate the entry: forward stock is described as thinner than for comparable entities, with less commonly ordered lines dispatching from Beijing and adding approximately one week.{{r|tally}} The tally is self-selected and measures reception rather than quality, and it is not comparable with the figure any other community publishes for the same organisation.{{r|tally}} | |
| + | 77 | ||
| + | 78 | == Regulatory position and legal status == | |
| + | 79 | The organisation is a commercial entity registered in the People's Republic of China. Nothing in the available record indicates a manufacturing authorisation, marketing authorisation or pharmacopoeial registration in any jurisdiction, and none should be inferred from a registered business scope, which is a licensing fact and not a quality assurance.{{r|registry}} | |
| + | 80 | ||
| + | 81 | Material labelled [[Research use only|for research use only]] is outside the regulatory framework that governs medicines. Its identity, purity, sterility and [[Bacterial endotoxin test|endotoxin]] content are not assured by any regulator, and a [[Certificate of analysis|certificate of analysis]] issued by a supplier is a claim by that supplier rather than an independent finding.{{r|ruo,usp1503}} | |
| + | 82 | ||
| 75 | == References == | 83 | == References == |
| 76 | {{reflist}} | 84 | {{reflist}} |